Provincia de Buenos Aires, Argentina

Tania Melina Rodríguez


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Tania Melina Rodríguez: Innovator in TGF-beta Research

Introduction

Tania Melina Rodríguez is a prominent inventor from Provincia de Buenos Aires, Argentina, recognized for her significant contributions to the field of biomedical research. With a focus on receptor biology, she has developed innovative solutions that have the potential to impact therapeutic strategies.

Latest Patents

Rodríguez holds a noteworthy patent, titled "Isoform of the TGF-beta receptor II". This invention describes an isoform of the TGF-beta receptor II, which consists of approximately 80 amino acids and is notable for the lack of a transmembrane domain. This isoform acts as a TGF-β1 agonist and includes the amino acid sequence set forth in SEQ ID No. 12. Additionally, it may exhibit the amino acid sequence outlined in SEQ ID No. 2 or sequences that share at least 85% sequence identity.

Career Highlights

Throughout her career, Tania has been associated with esteemed research institutions, including Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET) and Fundación Articular. Her work has advanced the knowledge and understanding of growth factor signaling, particularly relating to TGF-beta pathways, contributing vital insights into their biological roles and potential therapeutic applications.

Collaborations

In her journey as an inventor, Rodríguez has collaborated with talented researchers such as Ricardo Alfredo Dewey and Benito Jorge Velasco Zamora. These partnerships have fostered a collaborative research environment, enhancing innovation and the development of pioneering therapeutic strategies.

Conclusion

Tania Melina Rodríguez stands out as an accomplished inventor in the realm of TGF-beta receptor research. Her patent and collaborative efforts underline her commitment to advancing scientific knowledge and improving therapeutic interventions in cellular biology. As she continues her work, her contributions will be invaluable in shaping future innovations in the biomedical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…